Generation Bio Co.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2020 | $111 M | No. 2 | $50 to $250 million | equity | SEC | |
| Feb 2018 | $100 M | No. 1 | $50 to $250 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Generation Bio Co. chose not to state its revenue in its newest notice of a funding round (Jan 2020).
SEC Form D · Jan 2020
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jan 2020
That is all the official record says: Generation Bio Co. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
26 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Anthony G. Quinn | Person | not stated | not stated | Held Series C preferred stock, director (Form 3, 2020) | SEC Form 3 |
| Artal Group S.A. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Artal International Management S.A. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Artal Treasury Ltd | Company | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Atlas Venture Associates Opportunity I, LLC | Venture capital | not stated | not stated | Held Series A and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Atlas Venture Associates Opportunity I, L.P. | Venture capital | not stated | not stated | Held Series A and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Atlas Venture Associates X, LLC | Venture capital | not stated | not stated | Held Series A and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Atlas Venture Associates X, L.P. | Venture capital | not stated | not stated | Held Series A and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Atlas Venture Fund X, L.P. | Venture capital | not stated | not stated | Held Series A and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Atlas Venture Opportunity Fund I, L.P. | Venture capital | not stated | not stated | Held Series A and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Casdin Capital, LLC | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Catherine Stehman-Breen | Person | not stated | not stated | Held Series C preferred stock, director (Form 3, 2020) | SEC Form 3 |
| Charles A. Rowland Jr. | Person | not stated | not stated | Held Series C preferred stock, director (Form 3, 2020) | SEC Form 3 |
| Deerfield Management Company, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Deerfield Mgmt L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Deerfield Partners, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Donald William Nicholson | Person | not stated | not stated | Held Series A preferred stock, director (Form 3, 2020) | SEC Form 3 |
| Farallon Capital Management, L.L.C. | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Farallon Partners L L C/ca | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Geoff McDonough | Person | not stated | not stated | Held Series A preferred stock, 10% owner, director (Form 3, 2020) | SEC Form 3 |
| Gustav Christensen | Person | not stated | not stated | Held Series A, B and C preferred stock, director (Form 3, 2020) | SEC Form 3 |
| Invus Public Equities Advisors, LLC | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Invus Public Equities, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Fund or asset manager | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Westend SA | Company | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Zone Healthcare Holdings, LLC | Other | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 54 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Geoffrey McDonough | Executive officer | Jan 2020 |
| Mark Angelino | Executive officer | Jan 2020 |
| Thomas Graney | Executive officer | Jan 2020 |
| Geoff McDonoughy | Executive officer | Mar 2018 |
| Glenn Goddard | Executive officer | Mar 2018 |
| Anthony Quinn | Director | Jan 2020 |
| Catherine Stehman-Breen | Director | Jan 2020 |
| Charlie Rowland | Director | Jan 2020 |
| Donald Nicholson | Director | Jan 2020 |
| Geoffrey McDonough | Director | Jan 2020 |
| Gustav Christensen | Director | Jan 2020 |
| Jason Rhodes | Director | Jan 2020 |
| Jeff Jonas | Director | Jan 2020 |
| Geoff McDonoughy | Director | Mar 2018 |